世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医薬品スクリーニングの世界市場展望、2028年


Global Drug Screening Market Outlook, 2028

薬物検査業界は、雇用、スポーツ、ヘルスケア、法執行機関など、さまざまな分野で安全性と完全性を維持するために重要な役割を果たしています。薬物乱用の蔓延とその潜在的な影響により、薬物検査は、安全で健全... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Bonafide Research & Marketing Pvt. Ltd.
ボナファイドリサーチ 		2023年11月30日 US$4,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		165 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

薬物検査業界は、雇用、スポーツ、ヘルスケア、法執行機関など、さまざまな分野で安全性と完全性を維持するために重要な役割を果たしています。薬物乱用の蔓延とその潜在的な影響により、薬物検査は、安全で健全な環境づくりを目指す組織にとって標準的な慣行となっている。薬物検査のルーツは、主要な方法として尿検査が登場した20世紀半ばにまでさかのぼることができる。当初は軍や法執行機関で採用されていた薬物検査は、従業員の生産性と安全性への懸念から、1980年代に職場で広く受け入れられるようになった。長年にわたり、薬物検査業界は技術や方法論の進歩を取り入れながら発展してきた。今日、薬物検査は、尿、血液、唾液、毛髪など、さまざまな生体サンプルを分析することができ、それぞれ検出の窓と精度の面で明確な利点を提供しています。薬物スクリーニングは、血液、尿、その他の生体サンプル中の違法・合法物質を検出するために使用される技術である。この技術は、臨床試験のための候補薬を選択する前に、有望な治療法を見つけ、最適化する。ハイスループット・スクリーニング技術を用いて、特定の生物学的機能に対して大規模な化学物質ライブラリーをスクリーニングする。薬物検査は、学校や病院、大学やプロのスポーツ選手の職場、事故後の検査などで行われている。アルコールと薬物サプリメントの使用の増加、アスリートによるステロイドの違法使用は、すべて薬物スクリーニング市場の拡大に寄与している。薬物検査技術は、公共の安全を維持し、職場の完全性を確保し、さまざまな領域で基準を守るために不可欠なツールとなっている。これらの技術は、生物学的サンプル中の薬物の存在を検出する多様な方法を提供し、長年にわたって大きく発展してきた。エクスタシー、コカイン、アンフェタミン、鎮痛剤、大麻などの違法薬物の使用は、世界中でますます一般的になっています。指紋ベースの薬物検査は比較的新しいコンセプトです。指紋ベースの薬物検査の市場はまだ初期段階にあり、他の製品よりも成長が遅いと予想されている。サンプルを採取してから10分以内に、この装置はコカイン、アヘン、アンフェタミン、大麻をスクリーニングできる。この検査が広く利用されるようになれば、尿、毛髪、血液ベースの薬物検査に取って代わることが期待される。

Bonafide Research社の調査レポート「薬物スクリーニングの世界市場展望、2028年」によると、薬物スクリーニングの世界市場は、2022年の89.5億米ドルから増加し、2028年には150億米ドルを超えると予測されています。同市場は2023-28年までに年平均成長率10%以上で成長すると予測されています。多くの産業は、特に安全性を重視する職務に就く従業員に対して薬物検査を義務付ける規制の対象になっている。職場の安全が優先されるようになり、雇用主は薬物のない職場環境を確保するために薬物検査プログラムを導入するケースが増えている。様々な地域や国で大麻が合法化されたことで、雇用主は薬物のない職場を維持することに課題を抱えるようになった。そのため、最近の薬物使用や機能障害を正確に評価するため、より高度な薬物検査方法の必要性が高まっている。オピオイドの蔓延を含む薬物乱用問題の世界的な増加により、雇用主や組織は従業員の薬物使用への対応により警戒を強めている。薬物検査は、薬物乱用問題を早期に発見し、対処するための積極的な対策と考えられている。安全が最優先される業界（運輸、建設、医療など）では、事故を防ぎ、安全な職場環境を維持するために、薬物のない労働力を確保することが極めて重要です。薬物検査は、障害のある従業員に関連するリスクを軽減するための予防措置と見なされます。政府規制と業界標準の遵守は、薬物スクリーニング業界の成長の原動力である。輸送や医療を含む様々な部門は、規制要件を満たすために特定の薬物検査プロトコルを遵守する必要があります。グローバル化の進展に伴い、複数の管轄区域で事業を展開する企業は、従業員全体の一貫性を維持するために薬物検査の実施を求めています。この傾向は、標準化された検査方法を提供できる薬物スクリーニングサービスの成長に寄与している。薬物乱用が個人の健康と生産性に及ぼす悪影響に対する認識が高まっている。この認識により、雇用主は従業員の健康管理およびリスク管理プログラムの一環として薬物スクリーニングを優先するようになりました。薬物検査技術の進歩により、検査の正確性、効率性、侵襲性は向上している。毛髪検査や唾液検査といった新しい方法は、従来の尿検査に代わるものであり、雇用者に薬物スクリーニングの選択肢を提供している。

北米が世界の薬物スクリーニング市場を独占したのは、違法薬物の消費量の増加、薬物乱用を抑制するための政府資金の利用可能性、薬物スクリーニングを支援する法律、アルコール障害による事故の負担増などの要因によるものである。

北米、特に米国では、さまざまな産業で薬物検査を義務付ける規制の枠組みが確立されている。労働安全衛生局（OSHA）の規制、運輸省（DOT）の要件、その他の業界固有の規制は、職場での薬物スクリーニングの普及に寄与している。北米には、薬物検査とモニタリングシステムを奨励する強力な規制の枠組みだけでなく、確立された医療インフラがある。さらに、北米では薬物の使用頻度や中毒問題が増加しているため、薬物スクリーニングサービスの需要が高まっている。また、この地域にはいくつかの重要な薬物スクリーニング企業や研究所があり、これが市場の優位性に寄与している。さらに、スポーツ組織における職場安全への取り組みと厳格なアンチドーピングポリシーの普及は、北米における薬物スクリーニングサービスの需要を増加させている。この地域では薬物障害による事故の頻度が高まっており、北米における薬物スクリーニングの必要性が高まっている。2022年に米国で実施された最近の調査によると、交通事故で死傷した人の半数以上が血中にアルコールまたは薬物を含んでいた。近年、この地域の薬物スクリーニング事業は大幅な技術発展を遂げ、薬物スクリーニング検査の精度と感度が向上した。その結果、薬物スクリーニングは北米地域の様々な部門にとって、より信頼できる効果的な選択肢となっている。さらに、この地域の政府は薬物使用と闘うための資金を増やしている。北米には、輸送、医療、建設、製造など多様な産業があり、安全規制や薬物のない職場の必要性が特に強調されている。このような産業の多様性が、薬物スクリーニング・サービスに対する全体的な需要を高めている。北米では職場の安全が最も重要な関心事であり、厳格な安全基準が薬物検査プログラムの広範な実施に寄与している。輸送や建設のような安全に敏感な産業では、薬物検査はしばしば従業員と公衆の健康を確保するための要件です。

製品・サービス別では、消耗品部門が2022年に突出した市場シェアで市場を支配しており、2028年までこの支配が続くと推定される。

検査を簡単、正確、迅速に行うための改善されたソリューションを提供する先進的な消耗品の発売が増加していることが、市場の成長を加速させている。例えば、2019年8月、MedTest Dx, Inc.は2019 American Association for Clinical Chemistry (AACC) Annual Scientific MeetingでClinitox Calibrators and Controlsを発表した。これらのキャリブレーターとコントロールは、検査室がステップの測定をなくし、コントロールと認証の管理、材料の入手とセットアップの必要性、複数の取り扱いをなくすための確認試験を行う。検査キット、検体採取装置、関連サービスを含む消耗品は、しばしば薬物スクリーニング市場で重要な役割を果たす。薬物スクリーニングの需要は、職場、医療、法執行機関などさまざまな分野で高まっている。この需要の増加は、検査キットと関連消耗品の消費量の増加につながっている。薬物スクリーニングには、尿検査、唾液検査、毛髪検査、血液検査など、さまざまな検査方法がある。これらの検査方法にはそれぞれ専用の消耗品が必要です。さまざまな検査オプションが利用可能であることが、市場で使用される消耗品の多様性に寄与している。特に安全性が重要視される業界（運輸、医療、製造など）では、規制上の要件により、定期的な薬物検査が義務付けられていることが多い。規制基準に適合する消耗品は、組織がこれらの要件を満たすために極めて重要である。検査技術の進歩や、より高感度で特異的な検査の開発は、消耗品の需要に貢献しています。新しい検査方法では、正確で信頼性の高い結果を得るために、しばしば専用の消耗品が必要となります。即時検査キットや検体採取装置などの消耗品は、薬物スクリーニング・プロセスにおける利便性と効率性を提供します。迅速で使いやすい消耗品は、検査ワークフローの合理化に貢献します。世界的な薬物乱用問題の増加により、薬物スクリーニング・プログラムの実施に対する認識と取り組みが高まっている。このことが、薬物スクリーニング市場における消耗品の需要を牽引している。サンプルを検査機関に送る必要なく、現場で検査を実施できるポイント・オブ・ケア薬物検査の傾向が強まっている。この傾向は、ポイントオブケア検査装置で使用される消耗品の需要を高めている。

尿検査は、薬物の最も一般的な検査方法の1つである。非侵襲性やサンプル中の大量の薬物を検出できる能力など、尿検査に関連する利点が、予測期間中の同分野の成長を促進すると予想される。

尿検査は非侵襲的なサンプル採取方法であるため、薬物スクリーニングを受ける個人にとってより受け入れやすく快適である。針を刺す必要がある血液検査とは異なり、尿検査では尿サンプルを提供するだけである。尿サンプルの採取は比較的簡単なプロセスで、専門的なトレーニングも必要ありません。この手軽さが、職場や医療機関、リハビリ施設など、さまざまな場面で尿検査が広く採用されている理由です。尿検査は幅広い薬物の検出に有効であり、検出範囲も比較的広い。つまり、他の検査方法と比較して、使用後の長い期間、尿中の物質を特定することができる。尿検査法は長期にわたって標準化され、検証されてきたため、信頼性が高く、一貫性のある結果が得られる。この標準化は、規制要件を満たし、薬物スクリーニングの結果の正確性を確保するために極めて重要です。尿検査は一般的に、毛髪検査や血液検査などの代替検査法よりも費用対効果が高い。この費用対効果の高さが、特に大量の検査シナリオで広く使用される要因となっている。尿検査は規制機関に広く受け入れられ、認知されているため、さまざまな業界で薬物検査規制を遵守するための好ましい方法となっている。標準化された尿検査手順は、職場の薬物検査プログラムや法的な背景でしばしば指定されています。尿検査は、さまざまな薬物を同時に検出できるマルチパネル検査キットを使用して実施することができます。1つのサンプルで複数の物質をスクリーニングできるこの機能により、尿検査は効率的で包括的なものとなる。尿検査を受ける可能性が高いという認識は、特に薬物検査が日常的に行われている職場では、薬物使用の抑止力として働く可能性がある。この抑止効果は、薬物スクリーニング・プログラムを実施する組織にとってさらなる利点である。

薬物検査ラボは、その正確な結果によって薬物検査ラボが広く受け入れられていることと、特に先進国では効果的な検査を実施するために訓練された担当者がいることから、市場を支配し、分析期間中にかなりの成長を示すと予想される。

多くの産業、特に運輸、医療、製造など、安全が重視される職種は、薬物検査を義務付ける規制要件の対象となっている。薬物検査機関は、組織がこれらの規制を遵守し、安全な職場環境を確保するのに役立ちます。薬物検査ラボは、精巧な検査方法と機器を採用し、正確で信頼性の高い結果を保証します。そのプロセスは標準化され、検証されていることが多く、検査結果の信頼性に貢献しています。薬物検査機関には、分析化学、毒物学、およびその他の関連分野の専門知識を持つ専門家が配属されています。彼らの専門知識により、検査は高い精度で実施され、複雑な結果も正確に解釈することができます。薬物検査ラボは、尿、血液、唾液、毛髪などさまざまな種類のサンプルから複数の物質を検出できる幅広い検査パネルを提供しています。この柔軟性により、さまざまな業界のクライアントの多様なニーズに対応することができます。ラボは、薬物検査能力の最先端を維持するため、最先端の機器や技術に投資している。これには、質量分析、クロマトグラフィー、イムノアッセイ技術などの進歩が含まれ、高感度と特異性で幅広い薬物の検出を可能にしている。薬物検査ラボは、検査プロセス全体を通してサンプルの完全性を保証するために、厳格なChain of Custodyプロトコルに従っています。これは、法的および規制上の目的だけでなく、顧客や検査対象者の信頼を維持するためにも重要です。検査機関は検査結果の機密性を最優先し、厳格なデータ・セキュリティ対策を遵守します。このことは、医療や法律など、プライバシーと機密保持が最重要視される業界では特に重要です。薬物検査ラボは顧客と協力し、それぞれのニーズに合わせてカスタマイズされた検査プログラムを開発します。これには、検査パネルの設計、検査頻度の決定、変化する業界要件への対応などが含まれます。法的・法医学的な文脈では、薬物検査ラボは法的事件の証拠を提供する上で重要な役割を果たします。その検査結果の正確性と信頼性は、職場紛争、犯罪捜査、裁判などの法的手続きに不可欠である。

本レポートの対象企業

Abbott Laboratories, Laboratory Corporation, Drägerwerk AG & Co.KGaA、Siemens Healthineers、島津製作所、OraSure Technologies、Quest Diagnostics、Lifeloc Technologies, Inc、F. Hoffmann-La Roche AG、Bio-Rad Laboratories, Inc、Psychemedics Corporation、Agilent Technologies, Inc、Thermo Fisher Scientific Inc.

市場促進要因

- 厳しい規制と職場方針：様々な業界における薬物乱用に対する認識と懸念の高まりは、薬物検査に関する厳しい規制と職場方針の実施につながっている。これは特に運輸、医療、製造などの業界で顕著である。

- 検査方法の技術的進歩：より正確で迅速な検査方法の開発など、薬物検査技術の絶え間ない進歩が大きな推進力となっている。経口液検査、毛髪検査、ポイント・オブ・ケア検査などの技術革新が市場の成長に寄与している。

市場の課題

- プライバシーに関する懸念と法的問題：薬物検査プログラムの実施は、しばしばプライバシーや法的問題に対する懸念を引き起こす。薬物のない職場の必要性と個人のプライバシー権のバランスをとることは、企業や規制機関が直面する課題である。

- 進化する薬物乱用の状況：薬物乱用の状況は、新しい物質の出現や使用パターンの変化など、ダイナミックなものです。このような変化に対応するために薬物検査の方法を適応させることは、業界にとって課題となっています。

市場動向

- ポイントオブケア検査への需要の高まり：薬物使用の迅速かつ現場での検出を可能にするポイントオブケア検査の傾向が高まっています。これは、法執行機関や雇用前スクリーニングなど、即座の結果が重要な業界では特に有益である。

- 人工知能（AI）とデータ分析の統合：薬物検査におけるAIとデータ分析の統合は注目すべき傾向である。これらの技術は、結果の解釈の効率と精度を高め、大規模なデータセットの管理に役立ち、検査プロセス全体を改善する。

Covid-19の影響

COVID-19の流行は世界の医薬品検査市場に大きな影響を与え、課題と機会の両方をもたらした。サプライチェーンにおける広範な混乱、労働力の移動の制限、経済の不確実性は、薬物検査プログラムの実施に課題を突きつけた。多くの企業が業務上の制約に直面し、日常的な検査活動の一時的な停滞につながった。しかし、パンデミックは、特に医療や運輸などの基幹産業において、薬物のない職場を維持することの重要性を浮き彫りにした。さらに、戸締まりや社会的距離を置く措置の間に分散化された検査を行う必要性への対応として、遠隔検査やモバイル検査サービスの採用が広まっている。健康と安全に対する意識の高まりは、特にパンデミック対策に重要なセクターにおいて、薬物検査ソリューションへの需要を強めている。世界がポスト・パンデミック時代の進化する力学に適応するにつれ、薬物検査市場は、職場と公衆衛生の両方のニーズに対応する柔軟で利用しやすい検査ソリューションに重点を置きながら、継続的な革新を目撃することになりそうである。


主な動向

- 2022年12月、PhoreMost Ltd.とThinkCyte K.K.は、人工知能（AI）を利用した最新の表現型薬物スクリーニングの進展を目指した戦略的研究提携を発表した。

- 2022年4月、Saladax Biomedical, Inc.はJanssen Pharmaceutica NVから抗精神病薬検査の特許ポートフォリオを取得した。この知的財産（IP）ポートフォリオには17の特許ファミリーが含まれ、33の米国特許と296の米国外特許を取得している。

- 2022年4月、ヤンセンファーマシューティカルNVは抗精神病薬検査に関する特許ポートフォリオをサラダックスバイオメディカル社に売却した。この知的財産（IP）ポートフォリオには17の特許ファミリーがある。同社は現在、この戦略により抗精神病薬検査業界で主導的地位を占めている。

本レポートの考察

- 地域世界
- 歴史的な年2017
- 基準年2022
- 推定年2023
- 予測年2028

本レポートでカバーされている側面

- 薬物スクリーニングの世界市場、その価値と予測、セグメントとともに
- 地域別・国別の医薬品スクリーニング市場分析
- 様々な促進要因と課題
- 進行中のトレンドと開発
- 注目企業
- 戦略的提言

レポート対象地域と国

- 北米（米国、カナダ、メキシコ）
- ヨーロッパ（ドイツ、イギリス、フランス、スペイン、イタリア、ロシア）
- アジア太平洋（中国、日本、インド、オーストラリア、韓国）
- 南米（ブラジル、アルゼンチン、コロンビア）
- 中東・アフリカ（UAE、サウジアラビア、南アフリカ）

製品・サービス別

- 消耗品
- 分析機器
- 迅速検査機器
- 薬物スクリーニングサービス

サンプルタイプ別

- 尿サンプル
- 呼気サンプル
- 毛髪サンプル
- 口腔液サンプル
- その他の検体

エンドユーザー別

- 研究所
- 職場
- 病院
- その他

レポートのアプローチ

本レポートは、一次調査と二次調査を組み合わせたアプローチで構成されている。当初は、市場を理解し、市場に存在する企業をリストアップするために二次調査を行った。二次調査は、プレスリリースや企業の年次報告書などの第三者情報源、政府が作成した報告書やデータベースの分析で構成されている。二次情報源からデータを収集した後、一次調査は、市場がどのように機能しているかについて主要プレーヤーに電話インタビューを行い、市場のディーラーや流通業者と取引コールを行うことによって実施された。その後、消費者を地域別、階層別、年齢層別、性別に均等にセグメンテーションし、消費者への一次調査を開始した。一次データを入手した後は、二次ソースから入手した詳細の検証を開始した。

対象読者

本レポートは、業界コンサルタント、メーカー、サプライヤー、薬物スクリーニング業界関連団体・組織、政府機関、その他関係者が市場中心の戦略を立てる際に役立ちます。マーケティングやプレゼンテーションに加え、業界に関する競合知識を高めることもできます。








***注：ご注文確認後、報告書をお届けするまでに48時間（2営業日）かかります。

ページTOPに戻る


目次

Table of Contents
1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Covid-19 Effect
2.5. Supply chain Analysis
2.6. Policy & Regulatory Framework
2.7. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Global Drug Screening Market Outlook
6.1. Market Size By Value
6.2. Market Share By Region
6.3. Market Size and Forecast, By Geography
6.4. Market Size and Forecast, By Product and Service
6.5. Market Size and Forecast, By Sample Type
6.6. Market Size and Forecast, By End User
7. North America Drug Screening Market Outlook
7.1. Market Size By Value
7.2. Market Share By Country
7.3. Market Size and Forecast, By Product and Service
7.4. Market Size and Forecast, By Sample Type
7.5. Market Size and Forecast, By End User
7.6. United States Drug Screening Market Outlook
7.6.1. Market Size By Value
7.6.2. Market Size and Forecast By Product and Service
7.6.3. Market Size and Forecast By Sample Type
7.6.4. Market Size and Forecast By End User
7.7. Canada Drug Screening Market Outlook
7.7.1. Market Size By Value
7.7.2. Market Size and Forecast By Product and Service
7.7.3. Market Size and Forecast By Sample Type
7.7.4. Market Size and Forecast By End User
7.8. Mexico Drug Screening Market Outlook
7.8.1. Market Size By Value
7.8.2. Market Size and Forecast By Product and Service
7.8.3. Market Size and Forecast By Sample Type
7.8.4. Market Size and Forecast By End User
8. Europe Drug Screening Market Outlook
8.1. Market Size By Value
8.2. Market Share By Country
8.3. Market Size and Forecast, By Product and Service
8.4. Market Size and Forecast, By Sample Type
8.5. Market Size and Forecast, By End User
8.6. Germany Drug Screening Market Outlook
8.6.1. Market Size By Value
8.6.2. Market Size and Forecast By Product and Service
8.6.3. Market Size and Forecast By Sample Type
8.6.4. Market Size and Forecast By End User
8.7. United Kingdom Drug Screening Market Outlook
8.7.1. Market Size By Value
8.7.2. Market Size and Forecast By Product and Service
8.7.3. Market Size and Forecast By Sample Type
8.7.4. Market Size and Forecast By End User
8.8. France Drug Screening Market Outlook
8.8.1. Market Size By Value
8.8.2. Market Size and Forecast By Product and Service
8.8.3. Market Size and Forecast By Sample Type
8.8.4. Market Size and Forecast By End User
8.9. Italy Drug Screening Market Outlook
8.9.1. Market Size By Value
8.9.2. Market Size and Forecast By Product and Service
8.9.3. Market Size and Forecast By Sample Type
8.9.4. Market Size and Forecast By End User
8.10. Spain Drug Screening Market Outlook
8.10.1. Market Size By Value
8.10.2. Market Size and Forecast By Product and Service
8.10.3. Market Size and Forecast By Sample Type
8.10.4. Market Size and Forecast By End User
8.11. Russia Drug Screening Market Outlook
8.11.1. Market Size By Value
8.11.2. Market Size and Forecast By Product and Service
8.11.3. Market Size and Forecast By Sample Type
8.11.4. Market Size and Forecast By End User
9. Asia-Pacific Drug Screening Market Outlook
9.1. Market Size By Value
9.2. Market Share By Country
9.3. Market Size and Forecast, By Product and Service
9.4. Market Size and Forecast, By Sample Type
9.5. Market Size and Forecast, By End User
9.6. China Drug Screening Market Outlook
9.6.1. Market Size By Value
9.6.2. Market Size and Forecast By Product and Service
9.6.3. Market Size and Forecast By Sample Type
9.6.4. Market Size and Forecast By End User
9.7. Japan Drug Screening Market Outlook
9.7.1. Market Size By Value
9.7.2. Market Size and Forecast By Product and Service
9.7.3. Market Size and Forecast By Sample Type
9.7.4. Market Size and Forecast By End User
9.8. India Drug Screening Market Outlook
9.8.1. Market Size By Value
9.8.2. Market Size and Forecast By Product and Service
9.8.3. Market Size and Forecast By Sample Type
9.8.4. Market Size and Forecast By End User
9.9. Australia Drug Screening Market Outlook
9.9.1. Market Size By Value
9.9.2. Market Size and Forecast By Product and Service
9.9.3. Market Size and Forecast By Sample Type
9.9.4. Market Size and Forecast By End User
9.10. South Korea Drug Screening Market Outlook
9.10.1. Market Size By Value
9.10.2. Market Size and Forecast By Product and Service
9.10.3. Market Size and Forecast By Sample Type
9.10.4. Market Size and Forecast By End User
10. South America Drug Screening Market Outlook
10.1. Market Size By Value
10.2. Market Share By Country
10.3. Market Size and Forecast, By Product and Service
10.4. Market Size and Forecast, By Sample Type
10.5. Market Size and Forecast, By End User
10.6. Brazil Drug Screening Market Outlook
10.6.1. Market Size By Value
10.6.2. Market Size and Forecast By Product and Service
10.6.3. Market Size and Forecast By Sample Type
10.6.4. Market Size and Forecast By End User
10.7. Argentina Drug Screening Market Outlook
10.7.1. Market Size By Value
10.7.2. Market Size and Forecast By Product and Service
10.7.3. Market Size and Forecast By Sample Type
10.7.4. Market Size and Forecast By End User
10.8. Columbia Drug Screening Market Outlook
10.8.1. Market Size By Value
10.8.2. Market Size and Forecast By Product and Service
10.8.3. Market Size and Forecast By Sample Type
10.8.4. Market Size and Forecast By End User
11. Middle East & Africa Drug Screening Market Outlook
11.1. Market Size By Value
11.2. Market Share By Country
11.3. Market Size and Forecast, By Product and Service
11.4. Market Size and Forecast, By Sample Type
11.5. Market Size and Forecast, By End User
11.6. UAE Drug Screening Market Outlook
11.6.1. Market Size By Value
11.6.2. Market Size and Forecast By Product and Service
11.6.3. Market Size and Forecast By Sample Type
11.6.4. Market Size and Forecast By End User
11.7. Saudi Arabia Drug Screening Market Outlook
11.7.1. Market Size By Value
11.7.2. Market Size and Forecast By Product and Service
11.7.3. Market Size and Forecast By Sample Type
11.7.4. Market Size and Forecast By End User
11.8. South Africa Drug Screening Market Outlook
11.8.1. Market Size By Value
11.8.2. Market Size and Forecast By Product and Service
11.8.3. Market Size and Forecast By Sample Type
11.8.4. Market Size and Forecast By End User
12. Competitive Landscape
12.1. Competitive Dashboard
12.2. Business Strategies Adopted by Key Players
12.3. Key Players Market Share Insights and Analysis, 2022
12.4. Key Players Market Positioning Matrix
12.5. Porter's Five Forces
12.6. Company Profile
12.6.1. Abbott Laboratories
12.6.1.1. Company Snapshot
12.6.1.2. Company Overview
12.6.1.3. Financial Highlights
12.6.1.4. Geographic Insights
12.6.1.5. Business Segment & Performance
12.6.1.6. Product Portfolio
12.6.1.7. Key Executives
12.6.1.8. Strategic Moves & Developments
12.6.2. Laboratory Corporation
12.6.3. Drägerwerk AG & Co. KGaA
12.6.4. Siemens Healthineers
12.6.5. Shimadzu Corporation
12.6.6. OraSure Technologies
12.6.7. Quest Diagnostics
12.6.8. Lifeloc Technologies, Inc
12.6.9. F. Hoffmann-La Roche AG
12.6.10. Bio-Rad Laboratories, Inc.
12.6.11. Psychemedics Corporation
12.6.12. Agilent Technologies, Inc.
12.6.13. Thermo Fisher Scientific Inc
13. Strategic Recommendations
14. Annexure
14.1. FAQ`s
14.2. Notes
14.3. Related Reports
15. Disclaimer

List of Figures
Figure 1: Global Drug Screening Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Drug Screening Market Share By Region (2022)
Figure 6: North America Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: North America Drug Screening Market Share By Country (2022)
Figure 8: US Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: Canada Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: Mexico Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Europe Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 12: Europe Drug Screening Market Share By Country (2022)
Figure 13: Germany Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 14: UK Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 15: France Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 16: Italy Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 17: Spain Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 18: Russia Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 19: Asia-Pacific Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 20: Asia-Pacific Drug Screening Market Share By Country (2022)
Figure 21: China Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 22: Japan Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 23: India Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 24: Australia Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 25: South Korea Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 26: South America Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 27: South America Drug Screening Market Share By Country (2022)
Figure 28: Brazil Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 29: Argentina Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 30: Columbia Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 31: Middle East & Africa Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 32: Middle East & Africa Drug Screening Market Share By Country (2022)
Figure 33: UAE Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 34: Saudi Arabia Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 35: South Africa Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 36: Competitive Dashboard of top 5 players, 2022
Figure 37: Market Share insights of key players, 2022
Figure 38: Porter's Five Forces of Global Drug Screening Market

List of Table
Table 1 : Global Drug Screening Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2 : Influencing Factors for Drug Screening Market, 2022
Table 3: Top 10 Counties Economic Snapshot 2020
Table 4: Economic Snapshot of Other Prominent Countries 2020
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Drug Screening Market Size and Forecast, By Geography (2017 to 2028F) (In USD Billion)
Table 7 : Global Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 8 : Global Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 9 : Global Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 10 : North America Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 11 : North America Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 12 : North America Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 13 : United States Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 14 : United States Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 15 : United States Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 16 : Canada Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 17 : Canada Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 18 : Canada Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 19 : Mexico Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 20 : Mexico Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 21 : Mexico Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 22 : Europe Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 23 : Europe Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 24 : Europe Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 25 : Germany Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 26 : Germany Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 27 : Germany Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 28 : United Kingdom Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 29 : United Kingdom Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 30 : United Kingdom Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 31 : France Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 32 : France Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 33 : France Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 34 : Italy Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 35 : Italy Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 36 : Italy Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 37 : Spain Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 38 : Spain Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 39 : Spain Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 40 : Russia Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 41 : Russia Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 42 : Russia Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 43 : Asia-Pacific Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 44 : Asia-Pacific Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 45 : Asia-Pacific Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 46 : China Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 47 : China Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 48 : China Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 49 : Japan Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 50 : Japan Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 51 : Japan Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 52 : India Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 53 : India Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 54 : India Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 55 : Australia Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 56 : Australia Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 57 : Australia Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 58 : South Korea Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 59 : South Korea Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 60 : South Korea Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 61 : South America Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 62 : South America Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 63 : South America Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 64 : Brazil Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 65 : Brazil Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 66 : Brazil Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 67 : Argentina Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 68 : Argentina Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 69 : Argentina Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 70 : Colombia Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 71 : Colombia Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 72 : Colombia Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 73 : Middle East & Africa Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 74 : Middle East & Africa Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 75 : Middle East & Africa Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 76 : United Arab Emirates Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 77 : United Arab Emirates Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 78 : United Arab Emirates Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 79 : Saudi Arabia Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 80 : Saudi Arabia Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 81 : Saudi Arabia Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 82 : South Africa Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 83 : South Africa Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 84 : South Africa Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)

　

ページTOPに戻る


　

Summary

The drug testing industry plays a crucial role in maintaining safety and integrity across various sectors, including employment, sports, healthcare, and law enforcement. With the prevalence of substance abuse and its potential consequences, drug testing has become a standard practice for organizations aiming to create a secure and healthy environment. The roots of drug testing can be traced back to the mid-20th century, with the emergence of urine testing as the primary method. Initially employed by the military and law enforcement agencies, drug testing gained widespread acceptance in the workplace during the 1980s, driven by concerns about employee productivity and safety. Over the years, the drug testing industry has evolved, incorporating advancements in technology and methodologies. Today, drug tests can analyze various biological samples, including urine, blood, saliva, and hair, each offering distinct advantages in terms of detection windows and accuracy. Drug screening is a technique used to detect illegal and legal substances in blood, urine, and other biological samples. This technique finds and optimizes promising treatments prior to selecting a candidate drug for clinical trials. Large chemical libraries are screened for a specific biological function using high-throughput screening techniques. Drug testing is performed in schools, hospitals, and workplaces for college and professional athletes, as well as post-accident testing. The rising use of alcohol and drug supplements, as well as the illegal usage of steroids by athletes, all contributes to the expansion of the drug screening market. Drug testing techniques have become indispensable tools in maintaining public safety, ensuring workplace integrity, and upholding standards in various domains. These techniques have evolved significantly over the years, offering diverse methods to detect the presence of drugs in biological samples. The use of illegal drugs such as ecstasy, cocaine, amphetamines, pain relievers, and cannabis is growing more common throughout the world. Fingerprint-based drug testing is a relatively new concept. The market for fingerprint-based drug testing is still in its early stages and is expected to grow slowly than other products. Within 10 minutes of collecting a sample, this device can screen for cocaine, opiates, amphetamines, and cannabis. If this test becomes widely utilized, it is expected to replace urine, hair, and blood-based drug testing.

According to the research report, “Global Drug Screening Market Outlook, 2028” published by Bonafide Research, the Global Drug Screening market is anticipated to cross USD 15 Billion by 2028, increasing from USD 8.95 Billion in 2022. The market is expected to grow with more than 10% CAGR by 2023-28. Many industries are subject to regulations that require drug testing for employees, especially in safety-sensitive roles. As workplace safety becomes a priority, employers are increasingly implementing drug testing programs to ensure a drug-free work environment. The legalization of marijuana in various regions and countries has created challenges for employers in maintaining a drug-free workplace. This has led to an increased need for more advanced drug testing methods to accurately assess recent drug use and impairment. The global increase in substance abuse issues, including the opioid epidemic, has prompted employers and organizations to be more vigilant in addressing drug use among their employees. Drug testing is seen as a proactive measure to identify and address substance abuse problems early on. In industries where safety is paramount (such as transportation, construction, and healthcare), ensuring a drug-free workforce is crucial to prevent accidents and maintain a safe working environment. Drug testing is viewed as a preventive measure to mitigate risks associated with impaired employees. Compliance with government regulations and industry standards is a driving force behind the growth of the drug screening industry. Various sectors, including transportation and healthcare, are required to adhere to specific drug testing protocols to meet regulatory requirements. With increased globalization, companies operating in multiple jurisdictions seek drug testing practices to maintain consistency across their workforce. This trend contributes to the growth of drug screening services that can offer standardized testing methodologies. There is a growing awareness of the negative effects of substance abuse on individuals' health and productivity. This awareness has led employers to prioritize drug screening as part of their employee wellness and risk management programs. Advances in drug testing technologies have made testing more accurate, efficient, and less invasive. New methods such as hair and saliva testing offer alternatives to traditional urine tests, providing employers with more options for drug screening.

North America dominated the global Drug Screening market attributed to factors such as the growing consumption of illicit drugs, the availability of government funding to curb drug abuse, laws supporting drug screening and the growing burden of accidents due to alcohol impairment.

North America, particularly the United States, has a well-established regulatory framework that mandates drug testing in various industries. Occupational Safety and Health Administration (OSHA) regulations, Department of Transportation (DOT) requirements, and other industry-specific regulations contribute to a widespread adoption of drug screening in the workplace. North America has a well-established healthcare infrastructure as well as strong regulatory frameworks that encourage drug testing and monitoring systems. Furthermore, the increasing frequency of drug usage and addiction problems in North America has increased demand for drug screening services. The region is also home to several significant drug screening companies and laboratories, which contributes to its market dominance. Furthermore, the prevalence of workplace safety efforts and strict anti-doping policies in sports organizations has increased demand for drug screening services in North America. The growing frequency of accidents in the region caused by drug impairment is increasing the need for drug screening in North America. According to a recent survey conducted in the United States in 2022, more than half of those killed or wounded in road accidents had alcohol or drugs in their bloodstream. In recent years, the region's drug screening business has seen substantial technological developments, resulting in better accuracy and sensitivity of drug screening tests. As a result, drug screening has become a more trustworthy and effective alternative for a variety of sectors in the North American region. Furthermore, the region's government has increased its financing to combat drug usage. North America has a diverse range of industries, including transportation, healthcare, construction, and manufacturing, where safety regulations and the need for a drug-free workplace are particularly emphasized. This diversity in industries increases the overall demand for drug screening services. Workplace safety is a paramount concern in North America, and stringent safety standards contribute to the widespread implementation of drug testing programs. In safety-sensitive industries, such as transportation and construction, drug testing is often a requirement to ensure the well-being of employees and the public.

Based on the product & services, the consumables segment is dominating the market with prominent market share in 2022 and is estimated to continue this dominance by 2028.

The increasing launch of advanced consumables that provide improved solutions to make testing easy, accurate, and fast have accelerated the market growth. For instance, in August 2019, MedTest Dx, Inc. introduced Clinitox Calibrators and Controls at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting. These calibrators and controls perform confirmation testing for laboratories to eliminate measurement of steps and manage controls and certifications, need to acquire and set-up materials, and multiple handling. Consumables, including testing kits, specimen collection devices, and related services, often play a significant role in the drug screening market. The demand for drug screening has risen across various sectors, including workplaces, healthcare, and law enforcement. This increased demand has led to a higher consumption of testing kits and related consumables. Drug screening encompasses various testing methods, such as urine, saliva, hair, and blood tests. Each of these methods requires specific consumables. The availability of a range of testing options contributes to the diversity of consumables used in the market. Regulatory requirements, especially in industries where safety is a critical concern (such as transportation, healthcare, and manufacturing), often mandate regular drug testing. Consumables that comply with regulatory standards are crucial for organizations to meet these requirements. Advances in testing technologies and the development of more sensitive and specific tests contribute to the demand for consumables. New testing methods often require specialized consumables for accurate and reliable results. Consumables, such as instant testing kits and specimen collection devices, offer convenience and efficiency in the drug screening process. Quick and easy-to-use consumables contribute to streamlined testing workflows. The global increase in substance abuse issues has prompted greater awareness and efforts to implement drug screening programs. This, in turn, drives the demand for consumables in the drug screening market. There is a growing trend toward point-of-care drug testing, where tests can be conducted on-site without the need for samples to be sent to a laboratory. This trend has increased the demand for consumables used in point-of-care testing devices.

Urine testing is one of the most common testing methods for drugs. Benefits associated with urine testing such as non-invasiveness and the ability to detect large numbers of drugs in the sample are expected to drive the segment growth over the forecast period.

Urine testing is a non-invasive method of collecting samples, which makes it more acceptable and comfortable for individuals undergoing drug screening. Unlike blood tests, which require a needle stick, urine tests only involve providing a urine sample. Collecting a urine sample is a relatively straightforward process that doesn't require specialized training. This ease of collection contributes to the widespread adoption of urine testing in various settings, including workplaces, healthcare, and rehabilitation facilities. Urine testing is effective in detecting a broad range of drugs, and it has a relatively wide detection window. This means that substances can be identified in the urine for a longer period after use compared to some other testing methods. Urine testing methods have been standardized and validated over time, providing reliable and consistent results. This standardization is crucial for meeting regulatory requirements and ensuring the accuracy of drug screening outcomes. Urine testing is generally more cost-effective than some alternative testing methods, such as hair or blood testing. This cost-effectiveness has contributed to its widespread use, especially in high-volume testing scenarios. Urine testing is widely accepted and recognized by regulatory bodies, making it a preferred method for compliance with drug testing regulations in various industries. Standardized urine testing procedures are often specified in workplace drug testing programs and legal contexts. Urine testing can be conducted using multi-panel test kits that can detect a variety of drugs simultaneously. This capability to screen for multiple substances with a single sample makes urine testing efficient and comprehensive. The perception of the likelihood of undergoing urine testing can act as a deterrent for drug use, particularly in workplaces where drug testing is a routine practice. This deterrence effect is an additional benefit for organizations implementing drug screening programs.

Drug testing laboratories dominated the market and are expected to show considerable growth during the analysis period due to wide acceptance of drug testing laboratories owing to their accurate results and presence of trained personnel especially in developed countries for conducting effective tests.

Many industries, especially those involving safety-sensitive positions such as transportation, healthcare, and manufacturing, are subject to regulatory requirements mandating drug testing. Drug testing laboratories help organizations comply with these regulations and ensure a safe working environment. Drug testing laboratories employ sophisticated testing methods and equipment, ensuring accurate and reliable results. Their processes are often standardized and validated, contributing to the credibility of the results they provide. Drug testing laboratories are staffed with professionals who have expertise in analytical chemistry, toxicology, and other relevant fields. Their specialized knowledge ensures that testing is conducted with a high level of precision, and they can interpret complex results accurately. Drug testing laboratories offer a wide range of testing panels that can detect multiple substances in various sample types, including urine, blood, saliva, and hair. This flexibility allows them to cater to the diverse needs of clients across different industries. Laboratories invest in state-of-the-art equipment and technologies to stay at the forefront of drug testing capabilities. This includes advancements in mass spectrometry, chromatography, and immunoassay techniques, enabling the detection of a broad spectrum of drugs with high sensitivity and specificity. Drug testing laboratories follow strict chain of custody protocols to ensure the integrity of samples throughout the testing process. This is critical for legal and regulatory purposes, as well as to maintain the trust of clients and the individuals being tested. Laboratories prioritize the confidentiality of test results and adhere to strict data security measures. This is particularly important in industries where privacy and confidentiality are paramount, such as healthcare and legal contexts. Drug testing laboratories work with clients to develop customized testing programs tailored to their specific needs. This includes designing testing panels, determining the frequency of testing, and adapting to evolving industry requirements. In legal and forensic contexts, drug testing laboratories play a crucial role in providing evidence for legal cases. The accuracy and reliability of their testing results are essential for legal proceedings, including workplace disputes, criminal investigations, and court cases.

Companies Covered in this report:

Abbott Laboratories, Laboratory Corporation , Drägerwerk AG & Co. KGaA, Siemens Healthineers, Shimadzu Corporation , OraSure Technologies, Quest Diagnostics, Lifeloc Technologies, Inc, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Psychemedics Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc.

Market Drivers

• Stringent Regulations and Workplace Policies: Increasing awareness and concern about substance abuse in various industries have led to the implementation of strict regulations and workplace policies related to drug testing. This is particularly prominent in industries such as transportation, healthcare, and manufacturing.

• Technological Advancements in Testing Methods: The continuous advancement in drug testing technologies, such as the development of more accurate and rapid testing methods, has been a significant driver. Innovations like oral fluid testing, hair testing, and point-of-care testing contribute to the growth of the market.

Market Challenges

• Privacy Concerns and Legal Issues: The implementation of drug testing programs often raises concerns about privacy and legal issues. Balancing the need for a drug-free workplace with individual privacy rights is a challenge that companies and regulatory bodies face.

• Evolving Landscape of Drug Abuse: The landscape of drug abuse is dynamic, with the emergence of new substances and changing patterns of usage. Adapting drug testing methodologies to keep up with these changes poses a challenge to the industry.

Market Trends

• Rise in Demand for Point-of-Care Testing: There is a growing trend toward point-of-care testing, allowing for quicker and on-site detection of drug use. This is particularly beneficial in industries where immediate results are crucial, such as law enforcement or pre-employment screenings.

• Integration of Artificial Intelligence (AI) and Data Analytics: The integration of AI and data analytics in drug testing is a notable trend. These technologies enhance the efficiency and accuracy of result interpretation and help in managing large datasets, improving overall testing processes.

Covid-19 Impacts

The COVID-19 pandemic has significantly impacted the global drug testing market, introducing both challenges and opportunities. The widespread disruptions in supply chains, limitations on workforce mobility, and economic uncertainties have posed challenges to the implementation of drug testing programs. Many businesses faced operational constraints, leading to a temporary slowdown in routine testing activities. However, the pandemic has also underscored the importance of maintaining a drug-free workplace, especially in essential industries such as healthcare and transportation. Additionally, the adoption of remote and mobile testing services has gained traction as a response to the need for decentralized testing during lockdowns and social distancing measures. The heightened awareness of health and safety issues has reinforced the demand for drug testing solutions, particularly in sectors critical to pandemic response efforts. As the world adapts to the evolving dynamics of the post-pandemic era, the drug testing market is likely to witness continued innovation, with an emphasis on flexible and accessible testing solutions that address both workplace and public health needs.


Key Developments

• In December 2022, PhoreMost Ltd. and ThinkCyte K.K have announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI).

• In April 2022, Saladax Biomedical, Inc acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. This intellectual property (IP) portfolio includes 17 patent families and has resulted in 33 U.S. patents and 296 patents in ex-U.S. countries.

• In April 2022, Janssen Pharmaceutical NV sold its patent portfolio for antipsychotic medication testing to Saladax Biomedical, Inc. There are seventeen patent families in this intellectual property (IP) portfolio. The company now holds a leading position in the antipsychotic drug testing industry because of this strategy.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global Drug Screening market with its value and forecast along with its segments
• Region & Country-wise Drug Screening market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions & Countries covered in the report

• North America (United States, Canada, Mexico)
• Europe (Germany, United Kingdom, France, Spain, Italy, Russia)
• Asia-Pacific (China, Japan, India, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle-East & Africa (UAE, Saudi Arabia, South Africa)

By Product and Service

• Consumables
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Service

By Sample Type

• Urine Samples
• Breath Samples
• Hair Samples
• Oral Fluid Samples
• Other Samples

By End User

• Laboratories
• Workplaces
• Hospitals
• Others

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drug Screening industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.








***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.



ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Covid-19 Effect
2.5. Supply chain Analysis
2.6. Policy & Regulatory Framework
2.7. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Global Drug Screening Market Outlook
6.1. Market Size By Value
6.2. Market Share By Region
6.3. Market Size and Forecast, By Geography
6.4. Market Size and Forecast, By Product and Service
6.5. Market Size and Forecast, By Sample Type
6.6. Market Size and Forecast, By End User
7. North America Drug Screening Market Outlook
7.1. Market Size By Value
7.2. Market Share By Country
7.3. Market Size and Forecast, By Product and Service
7.4. Market Size and Forecast, By Sample Type
7.5. Market Size and Forecast, By End User
7.6. United States Drug Screening Market Outlook
7.6.1. Market Size By Value
7.6.2. Market Size and Forecast By Product and Service
7.6.3. Market Size and Forecast By Sample Type
7.6.4. Market Size and Forecast By End User
7.7. Canada Drug Screening Market Outlook
7.7.1. Market Size By Value
7.7.2. Market Size and Forecast By Product and Service
7.7.3. Market Size and Forecast By Sample Type
7.7.4. Market Size and Forecast By End User
7.8. Mexico Drug Screening Market Outlook
7.8.1. Market Size By Value
7.8.2. Market Size and Forecast By Product and Service
7.8.3. Market Size and Forecast By Sample Type
7.8.4. Market Size and Forecast By End User
8. Europe Drug Screening Market Outlook
8.1. Market Size By Value
8.2. Market Share By Country
8.3. Market Size and Forecast, By Product and Service
8.4. Market Size and Forecast, By Sample Type
8.5. Market Size and Forecast, By End User
8.6. Germany Drug Screening Market Outlook
8.6.1. Market Size By Value
8.6.2. Market Size and Forecast By Product and Service
8.6.3. Market Size and Forecast By Sample Type
8.6.4. Market Size and Forecast By End User
8.7. United Kingdom Drug Screening Market Outlook
8.7.1. Market Size By Value
8.7.2. Market Size and Forecast By Product and Service
8.7.3. Market Size and Forecast By Sample Type
8.7.4. Market Size and Forecast By End User
8.8. France Drug Screening Market Outlook
8.8.1. Market Size By Value
8.8.2. Market Size and Forecast By Product and Service
8.8.3. Market Size and Forecast By Sample Type
8.8.4. Market Size and Forecast By End User
8.9. Italy Drug Screening Market Outlook
8.9.1. Market Size By Value
8.9.2. Market Size and Forecast By Product and Service
8.9.3. Market Size and Forecast By Sample Type
8.9.4. Market Size and Forecast By End User
8.10. Spain Drug Screening Market Outlook
8.10.1. Market Size By Value
8.10.2. Market Size and Forecast By Product and Service
8.10.3. Market Size and Forecast By Sample Type
8.10.4. Market Size and Forecast By End User
8.11. Russia Drug Screening Market Outlook
8.11.1. Market Size By Value
8.11.2. Market Size and Forecast By Product and Service
8.11.3. Market Size and Forecast By Sample Type
8.11.4. Market Size and Forecast By End User
9. Asia-Pacific Drug Screening Market Outlook
9.1. Market Size By Value
9.2. Market Share By Country
9.3. Market Size and Forecast, By Product and Service
9.4. Market Size and Forecast, By Sample Type
9.5. Market Size and Forecast, By End User
9.6. China Drug Screening Market Outlook
9.6.1. Market Size By Value
9.6.2. Market Size and Forecast By Product and Service
9.6.3. Market Size and Forecast By Sample Type
9.6.4. Market Size and Forecast By End User
9.7. Japan Drug Screening Market Outlook
9.7.1. Market Size By Value
9.7.2. Market Size and Forecast By Product and Service
9.7.3. Market Size and Forecast By Sample Type
9.7.4. Market Size and Forecast By End User
9.8. India Drug Screening Market Outlook
9.8.1. Market Size By Value
9.8.2. Market Size and Forecast By Product and Service
9.8.3. Market Size and Forecast By Sample Type
9.8.4. Market Size and Forecast By End User
9.9. Australia Drug Screening Market Outlook
9.9.1. Market Size By Value
9.9.2. Market Size and Forecast By Product and Service
9.9.3. Market Size and Forecast By Sample Type
9.9.4. Market Size and Forecast By End User
9.10. South Korea Drug Screening Market Outlook
9.10.1. Market Size By Value
9.10.2. Market Size and Forecast By Product and Service
9.10.3. Market Size and Forecast By Sample Type
9.10.4. Market Size and Forecast By End User
10. South America Drug Screening Market Outlook
10.1. Market Size By Value
10.2. Market Share By Country
10.3. Market Size and Forecast, By Product and Service
10.4. Market Size and Forecast, By Sample Type
10.5. Market Size and Forecast, By End User
10.6. Brazil Drug Screening Market Outlook
10.6.1. Market Size By Value
10.6.2. Market Size and Forecast By Product and Service
10.6.3. Market Size and Forecast By Sample Type
10.6.4. Market Size and Forecast By End User
10.7. Argentina Drug Screening Market Outlook
10.7.1. Market Size By Value
10.7.2. Market Size and Forecast By Product and Service
10.7.3. Market Size and Forecast By Sample Type
10.7.4. Market Size and Forecast By End User
10.8. Columbia Drug Screening Market Outlook
10.8.1. Market Size By Value
10.8.2. Market Size and Forecast By Product and Service
10.8.3. Market Size and Forecast By Sample Type
10.8.4. Market Size and Forecast By End User
11. Middle East & Africa Drug Screening Market Outlook
11.1. Market Size By Value
11.2. Market Share By Country
11.3. Market Size and Forecast, By Product and Service
11.4. Market Size and Forecast, By Sample Type
11.5. Market Size and Forecast, By End User
11.6. UAE Drug Screening Market Outlook
11.6.1. Market Size By Value
11.6.2. Market Size and Forecast By Product and Service
11.6.3. Market Size and Forecast By Sample Type
11.6.4. Market Size and Forecast By End User
11.7. Saudi Arabia Drug Screening Market Outlook
11.7.1. Market Size By Value
11.7.2. Market Size and Forecast By Product and Service
11.7.3. Market Size and Forecast By Sample Type
11.7.4. Market Size and Forecast By End User
11.8. South Africa Drug Screening Market Outlook
11.8.1. Market Size By Value
11.8.2. Market Size and Forecast By Product and Service
11.8.3. Market Size and Forecast By Sample Type
11.8.4. Market Size and Forecast By End User
12. Competitive Landscape
12.1. Competitive Dashboard
12.2. Business Strategies Adopted by Key Players
12.3. Key Players Market Share Insights and Analysis, 2022
12.4. Key Players Market Positioning Matrix
12.5. Porter's Five Forces
12.6. Company Profile
12.6.1. Abbott Laboratories
12.6.1.1. Company Snapshot
12.6.1.2. Company Overview
12.6.1.3. Financial Highlights
12.6.1.4. Geographic Insights
12.6.1.5. Business Segment & Performance
12.6.1.6. Product Portfolio
12.6.1.7. Key Executives
12.6.1.8. Strategic Moves & Developments
12.6.2. Laboratory Corporation
12.6.3. Drägerwerk AG & Co. KGaA
12.6.4. Siemens Healthineers
12.6.5. Shimadzu Corporation
12.6.6. OraSure Technologies
12.6.7. Quest Diagnostics
12.6.8. Lifeloc Technologies, Inc
12.6.9. F. Hoffmann-La Roche AG
12.6.10. Bio-Rad Laboratories, Inc.
12.6.11. Psychemedics Corporation
12.6.12. Agilent Technologies, Inc.
12.6.13. Thermo Fisher Scientific Inc
13. Strategic Recommendations
14. Annexure
14.1. FAQ`s
14.2. Notes
14.3. Related Reports
15. Disclaimer

List of Figures
Figure 1: Global Drug Screening Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Drug Screening Market Share By Region (2022)
Figure 6: North America Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: North America Drug Screening Market Share By Country (2022)
Figure 8: US Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: Canada Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: Mexico Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Europe Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 12: Europe Drug Screening Market Share By Country (2022)
Figure 13: Germany Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 14: UK Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 15: France Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 16: Italy Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 17: Spain Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 18: Russia Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 19: Asia-Pacific Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 20: Asia-Pacific Drug Screening Market Share By Country (2022)
Figure 21: China Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 22: Japan Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 23: India Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 24: Australia Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 25: South Korea Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 26: South America Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 27: South America Drug Screening Market Share By Country (2022)
Figure 28: Brazil Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 29: Argentina Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 30: Columbia Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 31: Middle East & Africa Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 32: Middle East & Africa Drug Screening Market Share By Country (2022)
Figure 33: UAE Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 34: Saudi Arabia Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 35: South Africa Drug Screening Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 36: Competitive Dashboard of top 5 players, 2022
Figure 37: Market Share insights of key players, 2022
Figure 38: Porter's Five Forces of Global Drug Screening Market

List of Table
Table 1 : Global Drug Screening Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2 : Influencing Factors for Drug Screening Market, 2022
Table 3: Top 10 Counties Economic Snapshot 2020
Table 4: Economic Snapshot of Other Prominent Countries 2020
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Drug Screening Market Size and Forecast, By Geography (2017 to 2028F) (In USD Billion)
Table 7 : Global Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 8 : Global Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 9 : Global Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 10 : North America Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 11 : North America Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 12 : North America Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 13 : United States Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 14 : United States Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 15 : United States Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 16 : Canada Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 17 : Canada Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 18 : Canada Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 19 : Mexico Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 20 : Mexico Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 21 : Mexico Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 22 : Europe Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 23 : Europe Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 24 : Europe Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 25 : Germany Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 26 : Germany Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 27 : Germany Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 28 : United Kingdom Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 29 : United Kingdom Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 30 : United Kingdom Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 31 : France Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 32 : France Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 33 : France Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 34 : Italy Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 35 : Italy Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 36 : Italy Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 37 : Spain Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 38 : Spain Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 39 : Spain Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 40 : Russia Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 41 : Russia Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 42 : Russia Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 43 : Asia-Pacific Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 44 : Asia-Pacific Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 45 : Asia-Pacific Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 46 : China Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 47 : China Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 48 : China Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 49 : Japan Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 50 : Japan Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 51 : Japan Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 52 : India Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 53 : India Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 54 : India Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 55 : Australia Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 56 : Australia Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 57 : Australia Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 58 : South Korea Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 59 : South Korea Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 60 : South Korea Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 61 : South America Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 62 : South America Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 63 : South America Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 64 : Brazil Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 65 : Brazil Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 66 : Brazil Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 67 : Argentina Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 68 : Argentina Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 69 : Argentina Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 70 : Colombia Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 71 : Colombia Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 72 : Colombia Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 73 : Middle East & Africa Drug Screening Market Size and Forecast, By Product and Service (2017 to 2028F) (In USD Billion)
Table 74 : Middle East & Africa Drug Screening Market Size and Forecast, By Sample Type (2017 to 2028F) (In USD Billion)
Table 75 : Middle East & Africa Drug Screening Market Size and Forecast, By End User (2017 to 2028F) (In USD Billion)
Table 76 : United Arab Emirates Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 77 : United Arab Emirates Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 78 : United Arab Emirates Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 79 : Saudi Arabia Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 80 : Saudi Arabia Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 81 : Saudi Arabia Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)
Table 82 : South Africa Drug Screening Market Size and Forecast By Product and Service (2017 to 2028F) (In USD Billion)
Table 83 : South Africa Drug Screening Market Size and Forecast By Sample Type (2017 to 2028F) (In USD Billion)
Table 84 : South Africa Drug Screening Market Size and Forecast By End User (2017 to 2028F) (In USD Billion)

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

Bonafide Research & Marketing Pvt. Ltd. 社の最新刊レポート

本レポートと同じKEY WORD（drug）の最新刊レポート


よくあるご質問


Bonafide Research & Marketing Pvt. Ltd.社はどのような調査会社ですか?


Bonafide Research & Marketing Pvt. Ltd.は、最新の経済、人口統計、貿易、市場データを提供する市場調査・コンサルティング会社です。調査レポート、カスタムレポート、コ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/20　10:26

143.76 円

160.81 円

193.57 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.